Research Partnership Publishes a New Patient Living with Diabetes (LATAM) 2018 Report and New Reports Scheduled for 2019
Living with Diabetes LATAM is a report based on a new study conducted amongst approximately 116 Type 2 (T2D) diabetes patients in Brazil and 105 patients in Mexico. The study comprised of 30-minute quantitative online and qualitative telephone interviews with T2D patients.
The LATAM report is intended to help pharmaceutical companies developing products in diabetes in this region to gain a deeper understanding of how patients come to be diagnosed with it and how it impacts their day-to-day lives physically, emotionally and socially. It also explores patient attitudes and perceptions towards treatment, the healthcare professionals managing their condition, as well as identifying the types of support and education patients need at key stages of their journey.
Head of Living With, Mariel Metcalfe commented, “With an increase in prevalence to 14% of the population in Mexico and 9% of the population in Brazil, diabetes is now one of the leading causes of mortality and disability in Latin America. This report provides comprehensive, quantitative insights into patient behaviours, perceptions and needs, as well as their feelings at key stages of their journey living with Type 2 Diabetes.”
Currently being conducted in LATAM but looking to expand the survey to the US, EU and Asia, Living with Diabetes is just one in a series of reports offering comprehensive insight into the chronic disease patient journey from pre-diagnosis to stabilisation. The Living with Atopic Dermatitis (US), Crohn’s (EU & US), Lupus- SLE (EU & US), Non-alcoholic Steatohepatitis - NASH (US), Rheumatoid Arthritis (US), Psoriasis (EU), Psoriatic arthritis - PsA (EU) and Ulcerative Colitis (EU & US) reports are published and available to purchase.
Living with AS (US & US), Rheumatoid Arthritis (EU & Japan) and Non-alcoholic Steatohepatitis - NASH (EU) reports will be launched in the 1st quarter of 2019.
Visit www.researchpartnership.com/livingwith for more information.
More detailed findings from the study can be provided from Mariel Metcalfe on marielm@researchpartnership.com
Media Contact:
Mariel Metcalfe,
Head of Living with,
marielm@researchpartnership.com,
T: +44 7584 625 836
Julie Denny,
Marketing Director,
julied@researchpartnership.com,
T: +44 20 8069 5006
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
